* Astria TherapeuticS press release [https://seekingalpha.com/pr/20198655-astria-therapeutics-reports-second-quarter-2025-financial-results-and-provides-a-corporate] (NASDAQ:ATXS [https://seekingalpha.com/symbol/ATXS]): Q2 GAAP EPS of -$0.57 beats by $0.02.
* As of June 30, 2025, Astria had cash, cash equivalents and short-term investments of $259.2 million, compared to $328.1 million as of December 31, 2024.
MORE ON ASTRIA THERAPEUTICS
* Astria: Betting On Navenibart In The Crowded HAE Arena [https://seekingalpha.com/article/4801444-astria-betting-on-navenibart-in-the-crowded-hae-arena]
* Seeking Alpha’s Quant Rating on Astria TherapeuticS [https://seekingalpha.com/symbol/ATXS/ratings/quant-ratings]
* Historical earnings data for Astria TherapeuticS [https://seekingalpha.com/symbol/ATXS/earnings]
* Financial information for Astria TherapeuticS [https://seekingalpha.com/symbol/ATXS/income-statement]
Astria TherapeuticS GAAP EPS of -$0.57 beats by $0.02
Published 2 months ago
Aug 12, 2025 at 8:47 PM
Positive
Auto